
Specia Remedies India Private Limited
This company specializes in wholesale trading of pharmaceutical products and supplies various healthcare items.
This company specializes in wholesale trading of pharmaceutical products and supplies various healthcare items.
Specia Remedies India Private Limited (SRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 2015 (Nine years and seven months 30 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivas Musham, Vamshi Muniganti, and Subash Nijanapuram serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
-
U74900TG2015PTC099614
099614
Private Limited Indian Non-Government Company
03 Jul 2015
30 Nov 2021
31 Mar 2021
Unlisted
Roc Hyderabad
Specia Remedies India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivas Musham ![]() | Director | 03-Jul-2015 | Current |
Vamshi Muniganti ![]() | Director | 03-Jul-2015 | Current |
Subash Nijanapuram ![]() | Director | 03-Jul-2015 | Current |
Specia Remedies India Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.71% decrease. The company also saw a slight improvement in profitability, with a 1.81% increase in profit. The company's net worth Soared by an impressive increase of 35.95%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Specia Remedies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Specia Remedies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Specia Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Specia Remedies India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Specia Remedies India Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Specia Remedies India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Srinivas Musham was appointed as a Director was appointed as a Director on 03 Jul 2015 & has been associated with this company since 9 years 7 months .
Vamshi Krishna Muniganti was appointed as a Director was appointed as a Director on 03 Jul 2015 & has been associated with this company since 9 years 7 months .
Subash Chandra Bose Nijanapuram was appointed as a Director was appointed as a Director on 03 Jul 2015 & has been associated with this company since 9 years 7 months .
Specia Remedies India Private Limited was registered on 03 Jul 2015 with Roc Hyderabad & aged 9 years 7 months as per MCA records.
Specia Remedies India Private Limited was incorporated on 03 Jul 2015.
The authorized share capital of Specia Remedies India Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Specia Remedies India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Specia Remedies India Private Limited is H.No. 1-9-290/13, First Floor Vidyanagar India, Hyderabad, Telangana, 500044.
The corporate identification number (CIN) of Specia Remedies India Private Limited is U74900TG2015PTC099614 and the company number is 099614 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Specia Remedies India Private Limited has fallen by -0.71%.
The financial reports for the fiscal year 2020 indicates that The net worth of Specia Remedies India Private Limited has experienced an upsurge of 35.95%.
The most recent Balance Sheet for Specia Remedies India Private Limited was filed with the ROC on 31 Mar 2021.